Strikingly, glucose intolerance and obesity in ob/ob mice without CORT treatment were also improved in GR-mKO mice, indicating that muscle GR signaling contributes to obesity-related metabolic changes, regardless of systemic glucocorticoid levels. This evidence concerns the gene NR3C1 and obesity due to melanocortin 4 receptor deficiency.